 San Francisco Chronicle | FDA clears J&J drug for tough-to-treat TB MarketWatch Fewer than 100 Americans have MDR-TB, according to J&J, but FDA approval is likely to strengthen the chances for approval in regions where the disease is more prevalent, including India, China and Eastern Europe. However, the drug's potential side ... FDA backs the first new drug for TB in 40 years |
